The Effects of a Novel Nutritional Product on Nutrient Status and Digestive Health
AG1 - Nutritional Supplement
+ Placebo
Other Study
Summary
Study start date: August 14, 2023
Actual date on which the first participant was enrolled.This study explores how a new dietary supplement affects overall nutrient levels in the body and the health of the digestive system. It focuses on healthy men and women to understand the supplement's potential benefits. The significance of this study lies in its ability to reveal how this supplement could improve nutrient absorption and digestive health, which might help in developing better nutritional products in the future. Participants in this study are randomly assigned to receive either the novel supplement or a placebo, which is a harmless substance with no active ingredients. Neither the participants nor the researchers know who receives the supplement or the placebo, ensuring unbiased results. The effects are monitored by analyzing blood samples to check nutrient levels and examining changes in the gut microbiome, the collection of bacteria and other microorganisms in the digestive system. This approach helps in understanding the supplement's impact on both nutrient status and gut health.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.30 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 50 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
PlaceboStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Center for Applied Health Sciences
Canfield, United StatesOpen Center for Applied Health Sciences in Google Maps